London Healthcare Clinics Limited Filleted accounts for Companies House (small and micro)

LONDON HEALTHCARE CLINICS LIMITED - Company Information

3 false false false false false false false false false true false false false false false false No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 05989349 2022-04-01 2023-03-31 05989349 2023-03-31 05989349 2022-03-31 05989349 2021-04-01 2022-03-31 05989349 2022-03-31 05989349 core:FurnitureFittings 2022-04-01 2023-03-31 05989349 bus:Director1 2022-04-01 2023-03-31 05989349 core:WithinOneYear 2023-03-31 05989349 core:WithinOneYear 2022-03-31 05989349 core:AfterOneYear 2023-03-31 05989349 core:ShareCapital 2023-03-31 05989349 core:ShareCapital 2022-03-31 05989349 core:RetainedEarningsAccumulatedLosses 2023-03-31 05989349 core:RetainedEarningsAccumulatedLosses 2022-03-31 05989349 bus:SmallEntities 2022-04-01 2023-03-31 05989349 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 05989349 bus:AbridgedAccounts 2022-04-01 2023-03-31 05989349 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 05989349 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31

COMPANY REGISTRATION NUMBER: 05989349

London Healthcare Clinics Limited

Filleted Unaudited Abridged Financial Statements

31 March 2023

London Healthcare Clinics Limited

Abridged Financial Statements

Year ended 31 March 2023

Contents	Page

Abridged statement of financial position	1

Notes to the abridged financial statements	3

London Healthcare Clinics Limited

Abridged Statement of Financial Position

31 March 2023

	2023		2022
Note	£	£	£

Fixed assets

Tangible assets	5		21,089	28,119

Current assets

Debtors		–	9,636
Investments	6	32,000	–
Cash at bank and in hand		175,361	143,851
		---------	---------
		207,361	153,487

Creditors: amounts falling due within one year	100,364		64,539
	---------		---------
Net current assets		106,997	88,948
		---------	---------
Total assets less current liabilities		128,086	117,067

Creditors: amounts falling due after more than one year	28,416	–
	---------	---------
Net assets	99,670	117,067
	---------	---------

Capital and reserves

Called up share capital	120	120
Profit and loss account	99,550	116,947
	--------	---------
Shareholders funds	99,670	117,067
	--------	---------

These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.

For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .

All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 March 2023 in accordance with Section 444(2A) of the Companies Act 2006.

London Healthcare Clinics Limited

Abridged Statement of Financial Position (continued)

31 March 2023

These abridged financial statements were approved by the board of directors and authorised for issue on 21 November 2023 , and are signed on behalf of the board by:

Mr S Ayad
Director

Company registration number: 05989349

London Healthcare Clinics Limited

Notes to the Abridged Financial Statements

Year ended 31 March 2023

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ground floor, 38 Lombard Street, London, EC3V 9BS, London.

2. Statement of compliance

These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The abridged financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixtures & Fittings	-	25% reducing balance
Equipments	-	25% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2022: 3 ).

5. Tangible assets

	£
Cost
At 1 April 2022 and 31 March 2023	134,933
	---------
Depreciation
At 1 April 2022	106,814
Charge for the year	7,030
	---------
At 31 March 2023	113,844
	---------
Carrying amount
At 31 March 2023	21,089
	---------
At 31 March 2022	28,119
	---------

6. Investments

	2023	2022
	£	£
Other investments	32,000	–
	--------	----

7. Director's advances, credits and guarantees

At the year end Mr S Ayad owed the company £1,630 (2022: £9,636).

8. Related party transactions

During the year company paid £33,950 (2022: £15,000) as dividends to the shareholders. The company was under the control of Mr S Ayad throughout the current and previous year. Mr S Ayad is the managing director and majority shareholder.